Wallingford, PA, United States of America

Eugen F Mesaros

This inventor holds 13 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Drug Discovery. Top assignees: Cephalon, Inc., Venatorx Pharmaceuticals, Inc., Cancer Research Technology Limited. Active years: 2012-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eugen F Mesaros. Retrieved from https://idiyas.com/inventor/eugen-f-mesaros

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13 (Patent Applications = 7)

% Patents Active = 84.6

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 6 (Patent Applications = 14)

Average Co-Inventor Count = 9.2

ph-index = 3

Forward Citations = 34(Granted Patents)

Location History:

Philadelphia, PA (US) (2012)
Wallingford, PA (US) (2013 - 2022)

Company Filing History:

Venatorx Pharmaceuticals, Inc.

patents

3 out of 269

Cancer Research Technology Limited

patents

Years Active: 2012-2024

Loading Chart...

Areas of Expertise:

Penicillin-binding Protein

Beta-lactamase Inhibitors

Azaquinazoline

Protein Kinase C

Pyrrolotriazines

ALK Inhibitors

c-MET Inhibitors

JAK2 Inhibitors

2,4-Diaminopyrimidine

Triazolo Derivatives

Fused Bicyclic Derivatives

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12173018 - Penicillin-binding protein inhibitors (2024-12-24),

2. 11332485 - Penicillin-binding protein inhibitors (2022-05-17),

3. 11267826 - Penicillin-binding protein inhibitors (2022-03-08),

4. 10464952 - Beta-lactamase inhibitors (2019-11-05),

5. 10414763 - Azaquinazoline inhibitors of atypical protein kinase C (2019-09-17),

6. 9914730 - Azaquinazoline inhibitors of Atypical protein Kinase C (2018-03-13),

7. 9896446 - Azaquinazoline inhibitors of atypical protein kinase C (2018-02-20),

8. 9440984 - Pyrrolotriazines as ALK inhibitors (2016-09-13),

9. 8633173 - Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives (2014-01-21),

10. 8552186 - Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors (2013-10-08),

11. 8501936 - Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives (2013-08-06),

12. 8471005 - Pyrrolotriazines as ALK and JAK2 inhibitors (2013-06-25),

13. 8148391 - Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitors (2012-04-03),

Title: The Innovative Journey of Eugen F Mesaros

Introduction: Eugen F Mesaros, a talented inventor based in Wallingford, PA (US), has made significant contributions to the field of innovations with his creative mind and dedication to progress.

Latest Patents: Eugen F Mesaros holds several patents in various industries, showcasing his versatility and expertise in inventing cutting-edge solutions to complex problems.

Career Highlights: Throughout his illustrious career, Eugen F Mesaros has been recognized for his groundbreaking inventions that have revolutionized the way we approach technology. His commitment to pushing boundaries and exploring new possibilities has set him apart in the world of innovation.

Collaborations: Eugen F Mesaros has collaborated with leading companies, research institutions, and universities to bring his ideas to life. His ability to work effectively in multidisciplinary teams has led to the successful development of groundbreaking technologies.

Conclusion: In conclusion, Eugen F Mesaros stands as a beacon of innovation, inspiring others to think outside the box and pursue their creative visions. His remarkable journey as an inventor continues to shape the future of technology and drive progress in the industry.

Profile summary based on public USPTO records.